Protecting Community Oncology Practices in the Wake of the IRA
Explore the impact of the Inflation Reduction Act on community oncology practices and discover how new legislation aims to protect patient access to care.
In this episode of Pharmacy Focus: Oncology Edition, host Alex Gerlach speaks with Nick Ferreyros, managing director of Policy, Advocacy, and Communications at the Community Oncology Alliance (COA) about the Protecting Patient Access to Cancer and Complex Therapies Act and its potential impact on community oncology practices. The discussion unpacks how the Inflation Reduction Act has played out in practice, the challenges it has created for providers, pharmacists, and patients, and how this new legislation seeks to address those gaps. They also explore COA’s support of the bill and what’s at stake for community oncology if it does not move forward.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- IMS 2025: Pharmacist Role in Optimizing Outcomes with Elranatamab
September 22nd 2025
- Teen Angst, Adolescent Anguish: Could It Be Mental Illness?
September 22nd 2025
- How Fast-Melt Tablets Support Adherence and Patient Choice
September 22nd 2025